The launching ceremony of Nuolai Medical Brain Science Clinical Research Center and the signing ceremony for the Nuolai Medical Liver Cancer Vaccine Project

On December 14th, the Nuolai Medical Brain Science Clinical Research Center was inaugurated alongside the signing ceremony for the Nuolai Medical Hepatocellular Carcinoma (Liver Cancer) Vaccine Project.

In attendance were Bai Shuzhong, Chairman of the China Health Promotion Foundation and founding director, Yang Hongtao, Secretary of the Municipal Party Committee and Director of the Municipal People's Congress Standing Committee, Liu Panying, Member of the Municipal Party Committee and Minister of the Organization Department, Zhang Ying, Member of the Municipal Party Committee and Secretary-General, Jiang Yongbin, Deputy Director of the Municipal People's Congress Standing Committee, Zhang Peifeng, Secretary of the District Party Committee, Zhou Pengfei, Deputy Secretary of the District Party Committee and District Head, as well as Fang Zengyong, Member of the District Party Committee and Director of the Office, who attended the event.

Liu Panying stated in his address that Nuolai Medical is a backbone enterprise in the pharmaceutical and medical device industry chain, committed to constructing a health industry system that integrates production, learning, research, and market. The launch of the Nuolai Medical Brain Science Clinical Research Center and the signing of the Hepatocellular Carcinoma Vaccine Project will undoubtedly promote comprehensive advancements in medical technology, such as preventive treatment of major diseases, management of chronic illnesses, enhancement of immunity, anti-aging, and more. The municipal committee, government, and industry task force will strive to create a more favorable environment, provide higher-quality services, and fully support the enterprise's development.

Zhang Peifeng presided over the signing ceremony, expressing that the signing event in Taishan District will actively connect and provide proactive services, actively coordinate and resolve difficulties encountered during project advancement, and expedite the early production and effectiveness of the projects to serve the society. It is hoped that Nuolai Medical will bravely shoulder social responsibilities, scale the peaks of technological advancements, focus on the forefront of precision medicine, continue exploratory research, intensify medical-engineering cross-disciplinary collaborations, and enable medical technology to support the strategy of modernizing and strengthening the city.

The leaders present jointly initiated the establishment of Nuolai Medical Brain Science Clinical Research Center.

It is understood that a total investment of 600 million RMB will be injected into both Nuolai Medical Brain Science Clinical Research Center and the Hepatocellular Carcinoma Vaccine Project. This effort is committed to boosting the rapid development of Taian's medical industry. Through technological innovation, it aims to leverage a multi-billion RMB market in healthcare, fill the research and market gaps in the field of cell-targeted therapy in Taian City and even Shandong Province, and achieve new breakthroughs in disease prevention, diagnosis, treatment, and improvement of people's quality of life.